Celldex Therapeutics, Inc. (NASDAQ:CLDX – Get Free Report) shares were up 2.7% on Wednesday . The company traded as high as $39.81 and last traded at $39.66. Approximately 202,977 shares traded hands during trading, a decline of 77% from the average daily volume of 896,324 shares. The stock had previously closed at $38.60. Wall Street […]
Tyra Biosciences (NASDAQ:TYRA – Get Free Report)‘s stock had its “outperform” rating reiterated by Wedbush in a research report issued to clients and investors on Thursday, Benzinga reports. They currently have a $28.00 target price on the stock. Wedbush’s target price would suggest a potential upside of 67.46% from the stock’s previous close. A number […]
Natera, Inc. (NASDAQ:NTRA – Get Free Report) CFO Michael Burkes Brophy sold 2,202 shares of Natera stock in a transaction that occurred on Tuesday, January 23rd. The stock was sold at an average price of $65.86, for a total value of $145,023.72. Following the sale, the chief financial officer now owns 65,754 shares in the […]
Natera, Inc (NASDAQ:NTRA) Receives Average Rating of Buy from Analysts themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Natera, Inc. (NASDAQ:NTRA – Get Free Report) insider Jonathan Sheena sold 5,000 shares of Natera stock in a transaction dated Wednesday, January 3rd. The shares were sold at an average price of $60.30, for a total value of $301,500.00. Following the completion of the transaction, the insider now directly owns 469,743 shares in the company, […]